MRPL50 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.124800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.019200E-01
Normal-vs-Stage2
8.138400E-01
Normal-vs-Stage3
5.592600E-01
Normal-vs-Stage4
6.326000E-01
Stage1-vs-Stage2
7.021800E-01
Stage1-vs-Stage3
3.921000E-01
Stage1-vs-Stage4
8.872200E-01
Stage2-vs-Stage3
3.132600E-01
Stage2-vs-Stage4
9.028400E-01
Stage3-vs-Stage4
3.666000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.493600E-01
Normal-vs-AfricanAmerican
9.589800E-01
Normal-vs-Asian
3.342200E-01
Caucasian-vs-AfricanAmerican
8.536000E-01
Caucasian-vs-Asian
4.620200E-02
AfricanAmerican-vs-Asian
2.506800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.485000E-01
Normal-vs-Female
7.632800E-01
Male-vs-Female
7.094600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.428100E-02
Normal-vs-Age(41-60Yrs)
5.347400E-01
Normal-vs-Age(61-80Yrs)
9.243200E-01
Normal-vs-Age(81-100Yrs)
9.190600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.09410000451271E-08
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.01809999997204E-06
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.286200E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.661600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.528000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.853200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.341000E-01
Normal-vs-Daily Drinker
6.885200E-01
Normal-vs-Weekly Drinker
9.557600E-01
Normal-vs-Occasional Drinker
7.473600E-01
Normal-vs-Social Drinker
8.316600E-01
Non Drinker-vs-Daily Drinker
3.607000E-01
Non Drinker-vs-Weekly Drinker
9.423200E-01
Non Drinker-vs-Occasional Drinker
6.235800E-01
Non Drinker-vs-Social Drinker
8.826800E-01
Daily Drinker-vs-Weekly Drinker
4.294600E-01
Daily Drinker-vs-Occasional Drinker
1.846780E-01
Daily Drinker-vs-Social Drinker
2.767800E-01
Weekly Drinker-vs-Occasional Drinker
6.087800E-01
Weekly Drinker-vs-Social Drinker
8.170800E-01
Occasional Drinker-vs-Social Drinker
7.370600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.555900E-02
Normal-vs-Grade 2
4.135800E-02
Normal-vs-Grade 3
5.858300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.436800E-01
Grade 1-vs-Grade 3
9.944200E-01
Grade 1-vs-Grade 4
9.555900E-02
Grade 2-vs-Grade 3
1.563750E-01
Grade 2-vs-Grade 4
4.135800E-02
Grade 3-vs-Grade 4
5.858300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.942400E-01
Normal-vs-NonDiabetic
7.731200E-01
Diabetic-vs-NonDiabetic
4.605500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.661400E-01
Normal-vs-NoPancreatitis
8.449800E-01
Pancreatitis-vs-NoPancreatitis
3.937600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.260200E-01
Normal-vs-N1
7.833600E-01
N0-vs-N1
7.516800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.672200E-01
Normal-vs-TP53-NonMutant
6.562400E-01
TP53-Mutant-vs-TP53-NonMutant
5.175200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
